Antonia Cagnetta

2.6k total citations · 1 hit paper
38 papers, 1.2k citations indexed

About

Antonia Cagnetta is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, Antonia Cagnetta has authored 38 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Hematology, 24 papers in Molecular Biology and 16 papers in Oncology. Recurrent topics in Antonia Cagnetta's work include Multiple Myeloma Research and Treatments (15 papers), Histone Deacetylase Inhibitors Research (9 papers) and Chronic Myeloid Leukemia Treatments (8 papers). Antonia Cagnetta is often cited by papers focused on Multiple Myeloma Research and Treatments (15 papers), Histone Deacetylase Inhibitors Research (9 papers) and Chronic Myeloid Leukemia Treatments (8 papers). Antonia Cagnetta collaborates with scholars based in Italy, United States and United Kingdom. Antonia Cagnetta's co-authors include Michele Cea, Kenneth C. Anderson, Paul G. Richardson, Nikhil C. Munshi, Chirag Acharya, Yu‐Tzu Tai, Mike Zhong, Franco Patrone, Marco Gobbi and Alessio Nencioni and has published in prestigious journals such as Blood, Cancer Research and Scientific Reports.

In The Last Decade

Antonia Cagnetta

38 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Novel anti–B-cell maturation antigen antibody-drug conjugate (GSK2857916) selectively induces killing of multiple myeloma

2014 375 citations Yu‐Tzu Tai, Chirag Acharya et al. Blood profile →

Peers

Countries citing papers authored by Antonia Cagnetta

Since Specialization

Citations

This map shows the geographic impact of Antonia Cagnetta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antonia Cagnetta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antonia Cagnetta more than expected).

Fields of papers citing papers by Antonia Cagnetta

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antonia Cagnetta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antonia Cagnetta. The network helps show where Antonia Cagnetta may publish in the future.

Co-authorship network of co-authors of Antonia Cagnetta

This figure shows the co-authorship network connecting the top 25 collaborators of Antonia Cagnetta. A scholar is included among the top collaborators of Antonia Cagnetta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antonia Cagnetta. Antonia Cagnetta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Clonal hematopoiesis impacts frailty in newly diagnosed multiple myeloma patients: a retrospective multicenter analysis 2024 ·Scientific Reports ·(unknown), (unknown), Debora Soncini, Concetta Conticello, (unknown), (unknown), (unknown), (unknown), (unknown), Fabio Guolo, Maurizio Miglino, Antonia Cagnetta, (unknown), (unknown), Daniele Derudas, Francesco Di Raimondo, Domenico Coviello, Roberto M. Lemoli, Michele Cea	2
2	Daratumumab in the treatment of C3 glomerulopathy with monoclonal gammopathy: a case report and literature review 2023 ·Frontiers in Medicine ·Pasquale Esposito, Daniela Picciotto, (unknown), Elisa Russo, (unknown), Giovanna Cenacchi, Antonia Cagnetta, Michele Cea, Roberto M. Lemoli, Francesca Viazzi	2
3	Prognostic Impact of Minimal Residual Disease Assessment in Elderly Patients with Secondary Acute Myeloid Leukemia. a Comparison between CPX-351 and Intensified Fludarabine-Based Regimens 2021 ·Blood ·Fabio Guolo, Paola Minetto, Marino Clavio, Maurizio Miglino, R Marcolin, (unknown), (unknown), (unknown), (unknown), Elisabetta Tedone, Nicoletta Colombo, Enrico Carminati, (unknown), (unknown), Antonia Cagnetta, Michele Cea, Marco Gobbi, Roberto M. Lemoli	1
4	The Non-Coding RNA Landscape of Plasma Cell Dyscrasias 2020 ·Cancers ·Eugenio Morelli, Annamaria Gullà, Roberta Rocca, Cinzia Federico, Lavinia Raimondi, (unknown), Valter Agosti, Marco Rossi, Giosuè Costa, Gianluca Giavaresi, Abdel Kareem Azab, Antonia Cagnetta, Michele Cea, Pierosandro Tagliaferri, Antonino Neri, Nikhil C. Munshi, Giuseppe Viglietto, Pierfrancesco Tassone, Nicola Amodio	25
5	A simple cytofluorimetric score may optimize testing for biallelic CEBPA mutations in patients with acute myeloid leukemia 2019 ·Leukemia Research ·R Marcolin, Fabio Guolo, Paola Minetto, Marino Clavio, (unknown), Filippo Ballerini, (unknown), (unknown), Nicoletta Colombo, Enrico Carminati, (unknown), Elisabetta Tedone, Paola Contini, Rosa Mangerini, Annalisa Kunkl, Maurizio Miglino, Antonia Cagnetta, Michele Cea, Marco Gobbi, Roberto M. Lemoli	9
6	Nicotinic Acid Phosphoribosyltransferase Regulates Cancer Cell Metabolism, Susceptibility to NAMPT Inhibitors, and DNA Repair 2017 ·Cancer Research ·Francesco Piacente, Irene Caffa, Silvia Ravera, Giovanna Sociali, Mario Passalacqua, Valerio Gaetano Vellone, Pamela Becherini, Daniele Reverberi, Fiammetta Monacelli, Alberto Ballestrero, Patrizio Odetti, Antonia Cagnetta, Michele Cea, Aimable Nahimana, Michel A. Duchosal, Santina Bruzzone, Alessio Nencioni	83
7	Glutamine-Dependence Targeting By Asparaginase Significantly Increases Anti-Myeloma Activity of Proteasome Inhibitors 2017 ·Blood ·Paola Minetto, Debora Soncini, Antonia Cagnetta, Fabio Guolo, (unknown), (unknown), (unknown), (unknown), Maurizio Miglino, Letizia Canepa, Roberto M. Lemoli, Marco Gobbi, Michele Cea	1
8	miR-23b/SP1/c-myc forms a feed-forward loop supporting multiple myeloma cell growth 2016 ·Blood Cancer Journal ·Mariateresa Fulciniti, Nicola Amodio, (unknown), Antonia Cagnetta, Mehmet Samur, Chirag Acharya, Rao Prabhala, Patrizia D’Aquila, Dina Bellizzi, Giuseppe Passarino, Sophia Adamia, Antonino Neri, Zachary R. Hunter, S P Treon, Kristina Anderson, Pierfrancesco Tassone, Nikhil C. Munshi	50
9	SIRT6 Inhibition As a Novel Approach for Treating Acute Myeloid Leukemia 2016 ·Blood ·Michele Cea, Antonia Cagnetta, Debora Soncini, Paola Minetto, (unknown), Fabio Guolo, Nicoletta Colombo, Filippo Ballerini, Marino Clavio, Maurizio Miglino, Marco Gobbi, Roberto M. Lemoli	1
10	A Novel Anti-a Proliferation-Inducing Ligand Hapril.01A Monoclonal Antibody Targets Multiple Myeloma Cells in the Bone Marrow Microenvironment 2014 ·Blood ·Yu‐Tzu Tai, Chirag Acharya, Gang An, Mike Zhong, Michele Cea, Antonia Cagnetta, Hua Jiang, Hans van Eenennaam, Andrea van Elsas, Nikhil C. Munshi, Kenneth C. Anderson	1
11	Role of genotype-based approach in the clinical management of adult acute myeloid leukemia with normal cytogenetics 2014 ·Leukemia Research ·Antonia Cagnetta, Sophia Adamia, Chirag Acharya, Franco Patrone, Maurizio Miglino, Alessio Nencioni, Marco Gobbi, Michele Cea	32
12	Nicotinamide Phosphoribosyltransferase as a Target in Inflammation- Related Disorders 2013 ·Current Topics in Medicinal Chemistry ·Fabrizio Montecucco, Michele Cea, Antonia Cagnetta, Patrizia Damonte, Aimable Nahimana, Alberto Ballestrero, Alberto Del Río, Santina Bruzzone, Alessio Nencioni	21
13	New Insights Into Biology of Chronic Myeloid Leukemia: Implications in Therapy 2013 ·Current Cancer Drug Targets ·Michele Cea, Antonia Cagnetta, Alessio Nencioni, Marco Gobbi, Franco Patrone	9
14	Evaluating Treatment Response of Chronic Myeloid Leukemia: Emerging Science and Technology 2013 ·Current Cancer Drug Targets ·Antonia Cagnetta, Anna Garuti, (unknown), Michele Cea, Maurizio Miglino, Ilaria Rocco, (unknown), Giuseppina Fugazza, Gabriella Cirmena, Nicoletta Colombo, Raffaella Grasso, Alessio Nencioni, Marco Gobbi, Franco Patrone	9
15	Non Homologous End Joining, a Marker Of Genomic Instability Is Elevated In Multiple Myeloma: A New Prognostic Factor 2013 ·Blood ·Teresa Calimeri, Mehmet Samur, Nicola Amodio, Michele Cea, Antonia Cagnetta, Mariateresa Fulciniti, Sophia Adamia, Marco Rossi, Yu‐Tzu Tai, Fortunato Morabito, Abdel Kareem Azab, Stéphane Minvielle, Hervé Avet‐Loiseau, Li Cheng, Jean‐Bernard Lazaro, Kenneth C. Anderson, Masood A. Shammas, Pierfrancesco Tassone, Nikhil C. Munshi	1
16	Intracellular NAD⁺depletion induces autophagic death in multiple myeloma cells 2012 ·Autophagy ·Michele Cea, Antonia Cagnetta, Franco Patrone, Alessio Nencioni, Marco Gobbi, Kenneth C. Anderson	31
17	Tracking molecular relapse of chronic myeloid leukemia by measuring Hedgehog signaling status 2012 ·Leukemia & lymphoma ·Michele Cea, Antonia Cagnetta, Gabriella Cirmena, Anna Garuti, Ilaria Rocco, (unknown), Ivana Pierri, Daniele Reverberi, Alessio Nencioni, Alberto Ballestrero, Marco Gobbi, Angelo Michele Carella, Franco Patrone	6
18	New Insights into the Treatment of Multiple Myeloma with Histone Deacetylase Inhibitors 2012 ·Current Pharmaceutical Design ·Michele Cea, Antonia Cagnetta, Marco Gobbi, Franco Patrone, Paul G. Richardson, Teru Hideshima, Kenneth C. Anderson	1
19	WT1 overexpression at diagnosis may predict favorable outcome in patients withde novonon-M3 acute myeloid leukemia 2011 ·Leukemia & lymphoma ·Maurizio Miglino, Nicoletta Colombo, Gian-Matteo Pica, Raffaella Grasso, Marino Clavio, Micaela Bergamaschi, Filippo Ballerini, Anna Ghiso, Chiara Ghiggi, (unknown), Germana Beltrami, Antonia Cagnetta, (unknown), (unknown), Sara Aquino, Ivana Pierri, Mario Sessarego, Angelo Michele Carella, Marco Gobbi	32
20	Molecular diagnosis and monitoring of chronic myelogenous leukemia: BCR-Abl and more. 2010 ·PubMed ·Michele Cea, Antonia Cagnetta, Anna Garuti, Gabriella Cirmena, Ilaria Rocco, (unknown), (unknown), Alberto Ballestrero, Franco Patrone, Alessio Nencioni	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact